{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T17:58:09Z","timestamp":1793383089089,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T00:00:00Z","timestamp":1521072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s00467-018-3923-5","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T02:00:18Z","timestamp":1521079218000},"page":"1089-1092","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Idiopathic membranous nephropathy in children treated with rituximab: report of two cases"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4181-8744","authenticated-orcid":false,"given":"Rossana","family":"Malatesta-Muncher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen W.","family":"Eldin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Laurence H.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mini","family":"Michael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,15]]},"reference":[{"key":"3923_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck Jr","year":"2009","unstructured":"Beck LH Jr, Bonegio RG, Lambeau G, Back DM, Powell DW, Cummins TD, Klein JB, Salant DJ (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11\u201321","journal-title":"N Engl J Med"},{"key":"3923_CR2","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1007\/s00467-013-2574-9","volume":"28","author":"LN Cossey","year":"2013","unstructured":"Cossey LN, Walker PD, Chris PL (2013) Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28:2307\u20132311","journal-title":"Pediatr Nephrol"},{"key":"3923_CR3","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.2215\/CJN.03850414","volume":"9","author":"E Hoxha","year":"2014","unstructured":"Hoxha E, Harendza S, Pinnschmidt H, Panzer U, Stahl RAK (2014) M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy. Clin J Am Soc Nephrol 9:1883\u20131890","journal-title":"Clin J Am Soc Nephrol"},{"key":"3923_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1681\/ASN.2010090967","volume":"22","author":"W Qin","year":"2011","unstructured":"Qin W, Beck LH Jr, Zeng C, Chen Z, Li S, Zuo K, Salant DJ, Lui Z (2011) Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 22:1137\u20131143","journal-title":"J Am Soc Nephrol"},{"key":"3923_CR5","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ki.2010.34","volume":"77","author":"LH Beck Jr","year":"2010","unstructured":"Beck LH Jr, Salant DJ (2010) Membranous nephropathy: recent travel and new roads ahead. Kidney Int 77:765\u2013770","journal-title":"Kidney Int"},{"key":"3923_CR6","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/nep.12478","volume":"20","author":"V Kumar","year":"2015","unstructured":"Kumar V, Ramachandran R, Kumar A, Nada R, Suri D, Gupta A, Kohli HS, Gupta KL, Jha V (2015) Antibodies to M-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology 20:572\u2013575","journal-title":"Nephrology"},{"key":"3923_CR7","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.2215\/CJN.07210810","volume":"6","author":"JM Hofstra","year":"2011","unstructured":"Hofstra JM, Beck LH Jr, Beck DM, Wetzels JF, Salant DJ (2011) Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 6:1286\u20131291","journal-title":"Clin J Am Soc Nephrol"},{"key":"3923_CR8","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.2215\/CJN.10471013","volume":"9","author":"AP Bech","year":"2014","unstructured":"Bech AP, Hofstra JM, Brenchley PE, Wetzels JF (2014) Association of anti-PLA2R antibodies with outcomes after immunosuppressive therapy in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 9:1386\u20131392","journal-title":"Clin J Am Soc Nephrol"},{"key":"3923_CR9","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.2215\/CJN.01330209","volume":"4","author":"MA Hladunewich","year":"2009","unstructured":"Hladunewich MA, Troyanov S, Calafati J, Cattran DC, Metropolitan Toronto Glomerulonephritis registry (2009) The natural history of the non-nephrotic membranous nephropathy patient. Clin J Am Soc Nephrol 4:1417\u20131422","journal-title":"Clin J Am Soc Nephrol"},{"key":"3923_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/kisup.2012.13","volume":"2","author":"National Kidney Foundation","year":"2012","unstructured":"National Kidney Foundation (2012) KDIGO clinical practice guidelines for glomerulonephritis: idiopathic membranous nephropathy. Kidney Int Suppl 2:143\u2013153","journal-title":"Kidney Int Suppl"},{"key":"3923_CR11","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1038\/sj.ki.5002553","volume":"72","author":"DC Cattran","year":"2007","unstructured":"Cattran DC, Alexopoulos E, Heering P, Hoyer PF, Johnston A, Meyrier A, Ponticelli C, Saito T, Choukroun G, Nachman P, Praga M, Yoshikawa N (2007) Cyclosporine in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 72:1429\u20131447","journal-title":"Kidney Int"},{"key":"3923_CR12","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1681\/ASN.2012020181","volume":"23","author":"P Ruggenenti","year":"2012","unstructured":"Ruggenenti P, Cravedi P, Chianca A, Perna A, Ruggiero B, Gaspari F, Rambaldi A, Marasa M, Remuzzi G (2012) Rituximab in idiopathic membranous nephropathy. J Am Soc Nephol 23:1416\u20131425","journal-title":"J Am Soc Nephol"},{"key":"3923_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00467-008-1005-9","volume":"24","author":"RP Valentini","year":"2009","unstructured":"Valentini RP, Matoo TK, Kapur G, Imam A (2009) Membranous glomerulonephritis: treatment response and outcome in children. Pediatr Nephrol 24:301\u2013308","journal-title":"Pediatr Nephrol"},{"key":"3923_CR14","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00467-010-1671-2","volume":"26","author":"B Zhu","year":"2011","unstructured":"Zhu B, Huang J (2011) Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy. Pediatr Nephrol 26:637\u2013638","journal-title":"Pediatr Nephrol"},{"key":"3923_CR15","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1681\/ASN.2014070640","volume":"26","author":"P Ruggenenti","year":"2015","unstructured":"Ruggenenti P, Debiec H, Ruggiero B, Chianca A, Pele T, Gaspari F, Suardi F, Gagliardini E, Orisio S, Benigni A, Ronco P, Remuzzi G (2015) Antiphospholipase A2 receptor antibody titer predicts post rituximab outcome of membranous nephropathy. J Am Soc Nephrol 26:2545\u20132558","journal-title":"J Am Soc Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00467-018-3923-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3923-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-018-3923-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T12:40:39Z","timestamp":1581943239000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00467-018-3923-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,15]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3923"],"URL":"https:\/\/doi.org\/10.1007\/s00467-018-3923-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,15]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}